Illumina, Inc. (ILMN) stock
ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 14/3013% above fair value
$202.61+4.61 (+2.33%)
Close on Nov 17, 2026Market cap $30.63BP/E 34.8Yield –
Illumina price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Illumina's price to sales ratio was 7.2× on Nov 11, 2026, against 4.8× a year earlier. Over the last 5 years it ranged from 2.8× to 13.1×, with a median of 5.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 7.2× | +2.4 |
| 2025 | Dec 31, 2025 | 4.8× | −0.0 |
| 2024 | Dec 31, 2024 | 4.8× | +0.0 |
| 2023 | Dec 29, 2023 | 4.8× | −1.8 |
| 2022 | Dec 30, 2022 | 6.7× | −6.4 |
| 2021 | Dec 31, 2021 | 13.1× | −3.7 |
| 2020 | Dec 31, 2020 | 16.8× | +2.6 |
| 2019 | Dec 31, 2019 | 14.2× | +0.6 |
| 2018 | Dec 31, 2018 | 13.6× | +1.3 |
| 2017 | Dec 29, 2017 | 12.3× | +4.4 |
| 2016 | Dec 30, 2016 | 7.9× | −5.3 |
| 2015 | Dec 31, 2015 | 13.2× | −2.3 |
| 2014 | Dec 31, 2014 | 15.5× | +3.7 |
| 2013 | Dec 31, 2013 | 11.8× | +5.4 |
| 2012 | Dec 31, 2012 | 6.4× | +2.6 |
| 2011 | Dec 30, 2011 | 3.8× | −6.5 |
| 2010 | Dec 31, 2010 | 10.3× | +3.8 |
| 2009 | Dec 31, 2009 | 6.6× | – |
See a number that looks wrong?